"use strict";(self.webpackChunkdocs=self.webpackChunkdocs||[]).push([[2536],{3905:(e,t,o)=>{o.d(t,{Zo:()=>p,kt:()=>d});var n=o(7294);function r(e,t,o){return t in e?Object.defineProperty(e,t,{value:o,enumerable:!0,configurable:!0,writable:!0}):e[t]=o,e}function a(e,t){var o=Object.keys(e);if(Object.getOwnPropertySymbols){var n=Object.getOwnPropertySymbols(e);t&&(n=n.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),o.push.apply(o,n)}return o}function s(e){for(var t=1;t<arguments.length;t++){var o=null!=arguments[t]?arguments[t]:{};t%2?a(Object(o),!0).forEach((function(t){r(e,t,o[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(o)):a(Object(o)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(o,t))}))}return e}function i(e,t){if(null==e)return{};var o,n,r=function(e,t){if(null==e)return{};var o,n,r={},a=Object.keys(e);for(n=0;n<a.length;n++)o=a[n],t.indexOf(o)>=0||(r[o]=e[o]);return r}(e,t);if(Object.getOwnPropertySymbols){var a=Object.getOwnPropertySymbols(e);for(n=0;n<a.length;n++)o=a[n],t.indexOf(o)>=0||Object.prototype.propertyIsEnumerable.call(e,o)&&(r[o]=e[o])}return r}var c=n.createContext({}),l=function(e){var t=n.useContext(c),o=t;return e&&(o="function"==typeof e?e(t):s(s({},t),e)),o},p=function(e){var t=l(e.components);return n.createElement(c.Provider,{value:t},e.children)},m="mdxType",u={inlineCode:"code",wrapper:function(e){var t=e.children;return n.createElement(n.Fragment,{},t)}},f=n.forwardRef((function(e,t){var o=e.components,r=e.mdxType,a=e.originalType,c=e.parentName,p=i(e,["components","mdxType","originalType","parentName"]),m=l(o),f=r,d=m["".concat(c,".").concat(f)]||m[f]||u[f]||a;return o?n.createElement(d,s(s({ref:t},p),{},{components:o})):n.createElement(d,s({ref:t},p))}));function d(e,t){var o=arguments,r=t&&t.mdxType;if("string"==typeof e||r){var a=o.length,s=new Array(a);s[0]=f;var i={};for(var c in t)hasOwnProperty.call(t,c)&&(i[c]=t[c]);i.originalType=e,i[m]="string"==typeof e?e:r,s[1]=i;for(var l=2;l<a;l++)s[l]=o[l];return n.createElement.apply(null,s)}return n.createElement.apply(null,o)}f.displayName="MDXCreateElement"},1385:(e,t,o)=>{o.r(t),o.d(t,{assets:()=>c,contentTitle:()=>s,default:()=>u,frontMatter:()=>a,metadata:()=>i,toc:()=>l});var n=o(7462),r=(o(7294),o(3905));const a={title:"Pathogenic BRCA Mutations",sidebar_position:3},s="Cancers with Pathogenic BRCA Mutations",i={unversionedId:"use-cases/brca",id:"use-cases/brca",title:"Pathogenic BRCA Mutations",description:"From the PCAWG study, we retrieved 44 whole genomes of cancer samples with bi-allelic loss of BRCA1 or BRCA2 genes. We followed the previously published curation of germline and somatic mutations in these two genes.",source:"@site/docs/use-cases/brca.md",sourceDirName:"use-cases",slug:"/use-cases/brca",permalink:"/docs/use-cases/brca",draft:!1,editUrl:"https://github.com/hms-dbmi/chromoscope/tree/master/docs/docs/use-cases/brca.md",tags:[],version:"current",sidebarPosition:3,frontMatter:{title:"Pathogenic BRCA Mutations",sidebar_position:3},sidebar:"docsSidebar",previous:{title:"Biallelic Loss of Tumor suppressor",permalink:"/docs/use-cases/bi-allelic-loss"},next:{title:"Co-amplifications",permalink:"/docs/use-cases/co-amplifications"}},c={},l=[],p={toc:l},m="wrapper";function u(e){let{components:t,...o}=e;return(0,r.kt)(m,(0,n.Z)({},p,o,{components:t,mdxType:"MDXLayout"}),(0,r.kt)("h1",{id:"cancers-with-pathogenic-brca-mutations"},"Cancers with Pathogenic BRCA Mutations"),(0,r.kt)("p",null,"From the PCAWG study, we retrieved 44 whole genomes of cancer samples with bi-allelic loss of BRCA1 or BRCA2 genes. We followed the previously published curation of germline and somatic mutations in these two genes",(0,r.kt)("sup",{parentName:"p",id:"fnref-1"},(0,r.kt)("a",{parentName:"sup",href:"#fn-1",className:"footnote-ref"},"1")),". "),(0,r.kt)("p",null,"The visualization shows that while both display general chromosomal instability, BRCA1 cancers show the predominance of tandem duplications, while deletions dominate BRCA2 cancers. Additionally, the telomeric loss-of-heterozygosity segments characteristic of homologous recombination deficiency, often appear to be delineated by unbalanced translocations (",(0,r.kt)("a",{parentName:"p",href:"https://chromoscope.bio/?demoIndex=9&domain=1683276173.7073574-1699032388.9649158&external=https://somatic-browser-test.s3.amazonaws.com/pathogenicBrca/configs/pathogenicBrca.all.config.json"},"example"),"). "),(0,r.kt)("admonition",{type:"info"},(0,r.kt)("p",{parentName:"admonition"},"You can see cohort of 44 cancer genomes with BRCA1/2 loss using the following Chromoscope configuration:"),(0,r.kt)("p",{parentName:"admonition"},(0,r.kt)("a",{parentName:"p",href:"https://chromoscope.bio/?showSamples=true&external=https://somatic-browser-test.s3.amazonaws.com/pathogenicBrca/configs/pathogenicBrca.all.config.json"},"https://chromoscope.bio/?showSamples=true&external=https://somatic-browser-test.s3.amazonaws.com/pathogenicBrca/configs/pathogenicBrca.all.config.json"))),(0,r.kt)("div",{className:"footnotes"},(0,r.kt)("hr",{parentName:"div"}),(0,r.kt)("ol",{parentName:"div"},(0,r.kt)("li",{parentName:"ol",id:"fn-1"},"Nguyen, L., et al.  Pan-cancer landscape of homologous recombination deficiency. Nature Communications, 11(1), 5584 (2020).",(0,r.kt)("a",{parentName:"li",href:"#fnref-1",className:"footnote-backref"},"\u21a9")))))}u.isMDXComponent=!0}}]);